Search This Blog

Wednesday, September 30, 2020

Oxford will study top-selling prescription drug for potential COVID-19 treatment

Britain’s Oxford University said on Wednesday it would study whether the world’s best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients, the latest effort to repurpose existing drugs as potential coronavirus therapies.

The AVID-CC trial will test the anti-tumour necrosis factor (anti-TNF) drug and will be aimed at treating people in the community, especially in care homes. It will enrol up to 750 patients from community care settings throughout the UK.

https://www.reuters.com/article/us-health-coronavirus-oxford/oxford-will-study-top-selling-prescription-drug-for-potential-covid-19-treatment-idUSKBN26L1LM

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.